The Pre-Filled Syringes Market: 2016 – 2030 – Opportunities, Challenges, Strategies & Forecasts

Release Date: May 2016

Number of Pages: 179

Number of Tables and Figures: 83

Synopsis: A pre-filled syringe is a medical syringe that comes pre-filled with a specific dosage of medication. Representing one of the fastest growing segments of the injectable drug delivery ecosystem, pre-filled syringes offer significant benefits over the traditional ‘vial and syringe’ format, by increasing dosing accuracy, safety and convenience.

In addition, pre-filled syringes also offer a variety of economic benefits to pharmaceutical companies including a reduction in drug overfill and waste, which increases the saleable yield of the API (Active Pharmaceutical Ingredient).

SNS Research estimates that the market for pre-filled syringes will account for nearly $4 Billion in revenue by the end of 2016. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years.

The “Pre-Filled Syringes Market: 2016 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of the pre-filled syringes ecosystem including technology, market drivers, challenges, investment potential, leading therapies, use cases, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents market size forecasts for pre-filled syringe unit sales from 2016 through to 2030. The forecasts are further segmented for 4 horizontal submarkets, 10 drug classes, 5 regions and 15 leading countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

For a sample of the report or any further inquiries please contact info@snstelecom.com

Pricing: The report is available for the following price:

Single User License: USD 2,500

Company Wide License (Single Site): USD 3,500

Company Wide License (Global Site): USD 6,500

Key Findings:

The report has the following key findings:

  • SNS Research estimates that the market for pre-filled syringes will account for nearly $4 Billion in revenue by the end of 2016. Despite challenges relating to drug stability, manufacturing and competition from other drug delivery technologies, the market is poised for significant growth in the coming years.
  • In 2015, plastic based platforms accounted for just over 9% of the wider pre-filled syringes market. Over the next four years, the proportion of plastic pre-filled syringes is expected to increase by 6%, as drug developers seek to reduce the likelihood of breakage, while increasing the functionality of their products.
  • Many pre-filled syringe manufacturers now offer integrated automatic needle shielding or retractable needle options. In addition, specialist manufacturers have developed dual and multi chambered syringes to cater for drugs that must be reconstituted at the point of delivery.
  • Pre-filled pen systems and auto-injectors will grow at a CAGR of 21% over the next four years.

Topics Covered:

The report covers the following topics:

  • Pre-filled syringes ecosystem
  • Market drivers and barriers
  • Technology, safety mechanisms and key trends
  • Pen systems and auto-injectors
  • Industry roadmap and value chain
  • Analysis of leading drug classes and pre-filled syringe therapies
  • Profiles and strategies of over 80 leading ecosystem players, including manufacturers and pharmaceutical giants
  • Strategic recommendations for ecosystem players
  • Market analysis and forecasts from 2016 till 2030

Forecast Segmentation:

Market forecasts are provided for each of the following submarkets and their subcategories:

  • Material
    • Glass
    • Plastic
  • Injector Type
    • Conventional
    • Pen Systems & Auto-Injectors
  • Drug Class
    • Monoclonal Antibodies
    • Insulins
    • Erythropoietins
    • Interferons
    • G-CSF Agents
    • Anticoagulants
    • Recombinant Coagulation Factors
    • Vaccines
    • Growth Hormones
    • Others
  • Regional Markets
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • North America
    • Latin & Central America
  • Country Markets
    • Australia
    • Brazil
    • Canada
    • China
    • France
    • Germany
    • India
    • Italy
    • Japan
    • Mexico
    • Russia
    • South Korea
    • Spain
    • UK
    • USA

Key Questions Answered:

The report provides answers to the following key questions:

  • How big is the pre-filled syringes opportunity?
  • What factors are influencing its growth?
  • How is the ecosystem evolving by segment and region?
  • What will the market size be in 2020 and at what rate will it grow?
  • What trends, challenges and barriers are influencing its growth?
  • Who are the key market players and what are their strategies?
  • Which countries and submarkets will see the highest percentage of growth?
  • How will patent expiries of biologics impact the pre-filled syringes market?
  • What are the future prospects of multi chamber pre-filled syringes?
  • How does regulation impact pre-filled syringes?
  • What strategies should pre-filled syringe manufacturers adopt to remain competitive?

List of Companies Mentioned:

The following companies and organizations have been reviewed, discussed or mentioned in the report:

AbbVie

AI Biosciences

Ajinomoto Althea

Amgen

AMRI (Albany Molecular Research, Inc.)

Aptar Group

Aptar Stelmi

AptarGroup

Artemes Technologies

Aspen Pharmacare Holdings

AstraZeneca

Battelle

Baxter International

BD (Becton, Dickinson and Company)

Bespak

Biocon

Biogen

Bioneer

Boehringer Ingelheim

BSM (Bristol-Myers Squibb)

Catalent

Chugai Pharmaceuticals

Coldstream Laboratories

Consort Medical

Covidien

Credence MedSystems

Daikyo Seiko

Datwyler Sealing Solutions

Elcam Medical

Eli Lilly and Company

EMA (European Medicines Agency)

Enable Injections

Endo International

FAREVA

Fischer Clinical Services

Fresenius Kabi

Genentech

Gerresheimer

GSK (GlaxoSmithKline)

Guerbet

Haselmeier

Hospira

Hyaluron

Impax Laboratories

Ipsen

JLS (JSR Life Sciences)

Johnson & Johnson

JSR Corporation

Kaléo

KBI Biopharma

Laboratorios Farmacéuticos ROVI

Liebmann Group

LTI (Lyophilization Technology, Inc.)

Mallinckrodt

Medilet

MedImmune

MedPro Safety Products

Medtronic

Merck and Co.

Merck KGaA

MGC (MITSUBISHI GAS CHEMICAL)

MGlas

MHLW (Ministry of Health, Labour and Welfare, Japan)

Mitsubishi Group

Mylan

Nemera

Nipro Corporation

Novartis

Novo Nordisk

Noxilizer

Ompi (Stevanato Group)

OraTech

Oval Medical Technologies

Overlook Industries

Owen Mumford

PA Consulting

Pfanstiehl

Pfizer

Piramal Pharma Solutions

Regeneron Pharmaceuticals

Revolutions Medical Corporation

Roche Holding (F. Hoffmann-La Roche)

Roselabs

Sandoz

Sanofi

Schott

Schreiner MediPharm

SHL Group

SiO2 Medical Products

Sun Pharmaceutical Industries

Takeda Pharmaceutical Company

Terumo Corporation

Teva Pharmaceutical Industries

U.S. FDA (Food and Drug Administration)

Unilife Corporation

Ventana

Vetter Pharma International

Weigao Group (Shandong Weigao Group Medical Polymer Company)

West Pharmaceutical Services

Ypsomed

Yukon Medical

Zeon Corporation

Zogenix